{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:44:44Z","timestamp":1761630284093},"reference-count":36,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,6,1]]},"abstract":"<jats:p>Nonmyeloablative host conditioning regimens have been used in clinical allogeneic bone marrow and hematopoietic progenitor transplantation to effectively treat lymphohematopoietic tumors and reduce early toxicity. However, severe graft-versus-host disease (GVHD) remains a major problem. The goal of the current study was to determine whether specific subsets of cells in allogeneic bone marrow transplants can effectively treat the BCL1 B-cell lymphoma in nonmyeloablated BALB\/c mouse hosts given a single dose of sublethal (450 cGy) total body irradiation, without inducing severe GVHD. The experimental results show that high doses of whole bone marrow cells from major histocompatiblity complex (MHC)-mismatched donors eliminate both normal and malignant host-type lymphohematopoietic cells without causing injury to nonlymphohematopoietic host tissues. The CD8+T-cell antigen receptor\u2013\u03b1\u03b2+(TCR\u03b1\u03b2+) T cells within the marrow transplants mediated the killing of the tumor cells via both perforin- and FasL-dependent pathways. Cells present in marrow transplants from either CD8\u2212\/\u2212 or TCR\u03b1\u2212\/\u2212 donors failed to eliminate malignant and normal host lymphohematopoietic cells. Addition of small numbers of blood mononuclear cells to the marrow inoculum caused lethal GVHD. Thus, the resident allogeneic bone marrow CD8+ TCR\u03b1\u03b2+ T cells had the unique capacity to eliminate the host lymphohematopoietic cells without nonlymphohematopoietic tissue injury.<\/jats:p>","DOI":"10.1182\/blood.v97.11.3458","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"3458-3465","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor\u2013\u03b1\u03b2"],"prefix":"10.1182","volume":"97","author":[{"given":"Fengshuo","family":"Lan","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Division of Immunology and Rheumatology, and the Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Defu","family":"Zeng","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Immunology and Rheumatology, and the Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Huie","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Immunology and Rheumatology, and the Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Higgins","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Immunology and Rheumatology, and the Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Strober","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of Immunology and Rheumatology, and the Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021216075817500_B1","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood."},{"key":"2020021216075817500_B2","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: induction of graft versus malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol."},{"key":"2020021216075817500_B3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood."},{"key":"2020021216075817500_B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/bbmt.1999.v5.pm10465099","article-title":"Mixed chimerism: preclinical studies and clinical applications.","volume":"5","author":"McSweeney","year":"1999","journal-title":"Biol Blood Marrow Transplant."},{"key":"2020021216075817500_B5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.169.2.493","article-title":"Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.","volume":"169","author":"Sharabi","year":"1989","journal-title":"J Exp Med."},{"key":"2020021216075817500_B6","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.4049\/jimmunol.155.9.4179","article-title":"A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.","volume":"155","author":"Colson","year":"1995","journal-title":"J Immunol."},{"key":"2020021216075817500_B7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.153.3.1087","article-title":"Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.","volume":"153","author":"Tomita","year":"1994","journal-title":"J Immunol."},{"key":"2020021216075817500_B8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelo-suppressive conditioning.","volume":"3","author":"Sykes","year":"1997","journal-title":"Nat Med."},{"key":"2020021216075817500_B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-4804(83)90052-5","article-title":"The effect of peripheral lymphoid cells on the incidence of lethal graft versus host disease following allogeneic mouse bone marrow transplantation.","volume":"34","author":"Almaraz","year":"1983","journal-title":"J Surg Res."},{"key":"2020021216075817500_B10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow NK1.1\u2212 and NK1.1+ T cells reciprocally regulate acute graft versus host disease.","volume":"189","author":"Zeng","year":"1999","journal-title":"J Exp Med."},{"key":"2020021216075817500_B11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI108085","article-title":"Human bone marrow lymphocytes, I: distribution of lymphocyte subpopulations in the bone marrow of normal individuals.","volume":"56","author":"Fauci","year":"1975","journal-title":"J Clin Invest."},{"key":"2020021216075817500_B12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI108230","article-title":"Thymus-dependent lymphocytes in human bone marrow.","volume":"56","author":"Gale","year":"1975","journal-title":"J Clin Invest."},{"key":"2020021216075817500_B13","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1182\/blood.V86.7.2842.2842","article-title":"Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft versus host disease.","volume":"86","author":"Korbling","year":"1995","journal-title":"Blood."},{"key":"2020021216075817500_B14","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood.V85.11.3334.bloodjournal85113334","article-title":"Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.","volume":"85","author":"Negrin","year":"1995","journal-title":"Blood."},{"key":"2020021216075817500_B15","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V85.11.3302.bloodjournal85113302","article-title":"Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease.","volume":"85","author":"Johnson","year":"1995","journal-title":"Blood."},{"key":"2020021216075817500_B16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.178.2.703","article-title":"Donor CD8 cells prevent allogeneic graft rejection in mice: potential implications for marrow transplantation in humans.","volume":"178","author":"Martin","year":"1993","journal-title":"J Exp Med."},{"key":"2020021216075817500_B17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.150.1.197","article-title":"IL-2 reduces graft vs. host disease and preserves a graft vs. leukemia effect by selectively inhibiting CD4+ T cell activity.","volume":"150","author":"Sykes","year":"1993","journal-title":"J Immunol."},{"key":"2020021216075817500_B18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00007890-199508270-00010","article-title":"The role of purified CD8+ T cells in graft-vs.-leukemia activity and engraftment after allogeneic bone marrow transplantation.","volume":"60","author":"Palathumpat","year":"1995","journal-title":"Transplantation."},{"key":"2020021216075817500_B19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1083-8791(99)70012-1","article-title":"Graft-vs-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model.","volume":"5","author":"Ito","year":"1999","journal-title":"Biol Blood Marrow Transplant."},{"key":"2020021216075817500_B20","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood.V84.8.2436.2436","article-title":"Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.","volume":"84","author":"Kaufman","year":"1994","journal-title":"Blood."},{"key":"2020021216075817500_B21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1074-7613(00)80133-8","article-title":"CD8+TCR+ and CD8+TCR\u2212 cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers.","volume":"11","author":"Gandy","year":"1999","journal-title":"Immunity."},{"key":"2020021216075817500_B22","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T-cell-depleted bone marrow overcome MHC barriers in sublethally irradiated mice.","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med."},{"key":"2020021216075817500_B23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.1979.tb00303.x","article-title":"Immunobiology of a spontaneous murine B cell leukemia (BCL1).","volume":"48","author":"Strober","year":"1979","journal-title":"Immunol Rev."},{"key":"2020021216075817500_B24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.179.3.873","article-title":"Purification and characterization of the Fas-ligand that induces apoptosis.","volume":"179","author":"Suda","year":"1994","journal-title":"J Exp Med."},{"key":"2020021216075817500_B25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell mediated cytotoxicity.","volume":"265","author":"Kagi","year":"1994","journal-title":"Science."},{"key":"2020021216075817500_B26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiologic mechanisms of acute graft-vs.-host disease.","volume":"5","author":"James","year":"1999","journal-title":"Biol Blood Marrow Transplant."},{"key":"2020021216075817500_B27","first-page":"18","article-title":"Antibodies to IFN-gamma prevent immunological mediated intestinal damage in murine graft-versus-host reactions.","volume":"68","author":"Mowat","year":"1989","journal-title":"Immunology."},{"key":"2020021216075817500_B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00007890-199701150-00003","article-title":"High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing.","volume":"63","author":"Ricordi","year":"1997","journal-title":"Transplantation."},{"key":"2020021216075817500_B29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.4049\/jimmunol.130.5.2452","article-title":"Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.","volume":"130","author":"Weiss","year":"1983","journal-title":"J Immunol."},{"key":"2020021216075817500_B30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF01789175","article-title":"Characterization of the effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.","volume":"31","author":"Weiss","year":"1990","journal-title":"Cancer Immunol Immunother."},{"key":"2020021216075817500_B31","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4049\/jimmunol.137.4.1376","article-title":"Tumor dormancy, I: regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.","volume":"137","author":"Siu","year":"1886","journal-title":"J Immunol."},{"key":"2020021216075817500_B32","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.4049\/jimmunol.130.5.2452","article-title":"Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.","volume":"130","author":"Weiss","year":"1983","journal-title":"J Immunol."},{"key":"2020021216075817500_B33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00007890-199804150-00015","article-title":"Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation.","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation."},{"key":"2020021216075817500_B34","first-page":"904","article-title":"Characterization of a newly discovered T-cell receptor \u03b2-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment.","volume":"8","author":"Schuchert","year":"2000","journal-title":"Nature."},{"key":"2020021216075817500_B35","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","article-title":"Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.","volume":"91","author":"Alyea","year":"1998","journal-title":"Blood."},{"key":"2020021216075817500_B36","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.95.17.10152","article-title":"T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.","volume":"95","author":"Smit","year":"1998","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/11\/3458\/1674307\/h8110103458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/11\/3458\/1674307\/h8110103458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T06:43:05Z","timestamp":1704523385000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/11\/3458\/107522\/Allogeneic-bone-marrow-cells-that-facilitate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,6,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.11.3458","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6,1]]}}}